Table 2 Distribution of vancomycin-resistant enterococci (VRE) and methicillin-resistant Staphylococcus aureus (MRSA) isolates by clinical specimen
VRE isolates | MRSA isolates | |||||
|---|---|---|---|---|---|---|
Specimen, n (%) | Total | Cases | Controls | Total | Cases | Controls |
Negative | 335 (85.9) | 172 (88.2) | 163 (83.6) | 228 (58.5) | 81 (41.5) | 147 (75.4) |
Positive | 55 (14.1) | 23 (11.8) | 32 (16.4) | 162 (41.5) | 114 (58.5) | 50 (25.6) |
Urine | 41 (10.5) | 17 (8.7) | 24 (12.3) | 2 (0.5) | 2 (1.0) | 0 |
Wound | 1 (0.3) | 1 (0.5) | 0 | 7 (1.8) | 3 (1.5) | 4 (2.1) |
Blood | 7 (1.8) | 3 (1.5) | 4 (2.1) | 13 (3.3) | 5 (2.6) | 8 (4.1) |
Bile | 1 (0.3) | 0 | 1 (0.5) | 0 | 0 | 0 |
Sputum | 1 (0.3) | 0 | 1 (0.5) | 128 (32.8) | 95 (48.7) | 33 (16.9) |
Tip of drainage catheter | 2 (0.5) | 1 (0.5) | 1 (0.5) | 3 (0.8) | 1 (0.5) | 2 (1.0) |
Others* | 2 (0.5) | 1 (0.5) | 1 (0.5) | 9 (2.3) | 8 (4.1) | 1 (0.5) |
Total | 390 (100) | 195 (100) | 195 (100) | 390 (100) | 195 (100) | 195 (100) |